New drugs line up to challenge Ozempic, Wegovy for weight loss
Source: Medical Xpress
Lilly's experimental drug orforglipron comes from the blockbuster class of diabetes/weight-loss meds called glucagon-like peptide-1 agonists (GLP-1 agonists) that include Ozempic and Wegovy.